gms | German Medical Science

66th Annual Meeting of the German Society of Neurosurgery (DGNC)
Friendship Meeting with the Italian Society of Neurosurgery (SINch)

German Society of Neurosurgery (DGNC)

7 - 10 June 2015, Karlsruhe

Perspectives of SCS at refractory angina pectoris

Meeting Abstract

  • M.-Enes Gündüz - Neurochirurgische Klinik, Klinikum Ingolstadt
  • Michael Schmutzler - Neurochirurgische Klinik, Klinikum Ingolstadt
  • Richard Brucker - Neurochirurgische Klinik, Klinikum Ingolstadt
  • Siamak Asgari - Neurochirurgische Klinik, Klinikum Ingolstadt

Deutsche Gesellschaft für Neurochirurgie. 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC). Karlsruhe, 07.-10.06.2015. Düsseldorf: German Medical Science GMS Publishing House; 2015. DocDI.20.08

doi: 10.3205/15dgnc219, urn:nbn:de:0183-15dgnc2192

Published: June 2, 2015
Published with erratum: June 9, 2015

© 2015 Gündüz et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Background: The coronary artery disease is the most common cause of death in industrialized countries – in Germany approximately 200.000 heart strokes are recognized every year. Refractory angina pectoris (AP) is a chronic condition characterized by the presence of angina caused by coronary insufficiency in the presence of coronary artery disease which cannot be controlled by a combination of medical therapy, angioplasty and coronary bypass surgery. In these cases an implantation of Spinal Cord Stimulation System can be useful.

Material and Methods: From 2004 to 2014 nine patients with refractory AP underwent implantation of a Spinal-cord-stimulation (SCS)-System at our department. Seven patients have been interviewed with a modified version of the Seattle Angina Questionnaire, which is the leading health-related quality-of-life measure for people with coronary artery disease, contenting twelve questions.

Results: Five patients specify that the frequency of angina attacks is clearly reduced (from averagely three times each day to no attacks in the last four weeks) after three months of implantation of the SCS system. Additionally, the intake of nitro decreased in all patients.

Conclusion: SCS device implantation is able to treat severe AP in coronary artery disease after insufficiency of conventional medical therapy and revascularisation procedures. Further studies with large patient numbers are necessary to corroborate our results.


Erratum

The text of the abstract has been modified on June 9, 2015.